RNA modification sequencing, RIP-based profiling, arrays and GlycoRNA solutions
Arraystar RNA Modification
Research Expert
RESOURCES / TECHNICAL REVIEW

Reading the cap end: m6Am and cap-proximal methylation

One methyl group on the first nucleotide behind the cap, and a whole transcript carrying the same chemistry somewhere in its body. They are written by different enzymes, they mean different things, and only one of them can be attributed from a profile that does not separate the two.

01What this article answers

This article is about a question of position rather than of chemistry. m6Am is the methylated form of the adenosine that sits at the very start of the transcript, behind the cap. Internal m6A carries the same methyl group on adenosines elsewhere in the transcript. A method that reports “m6A” without saying which of the two it has captured has not answered either question.

The distinction matters because the two positions are associated with different biology. The cap-proximal position belongs to the machinery that handles the 5′ end of the transcript: how the cap is recognized, when it is removed and how long the transcript survives. Internal m6A belongs to the transcript body and is read against splicing, export and translation. The sections below set out what separates the two measurements, and what a profile of the cap end can and cannot support.

02Where the two positions differ

The chemistry is the same on both. Everything else about them differs.

The cap-proximal adenosine is a single nucleotide in a defined place. Every transcript has exactly one such position, and the modification there is either present or not, at some fraction across the molecules of that transcript. Internal m6A is distributed: zero, one or several positions per transcript, each with its own level, and a profile that covers the transcript body describes a landscape rather than a switch.

That difference is also why the two are written and removed by different machinery. The cap-proximal position is methylated by its own writer, and the eraser that has been reported for that position is the same enzyme that has been discussed for internal m6A — which is precisely why a study has to say which molecule and which position it measured before it attributes an effect.

Cap-proximal m6AmInternal m6A
Where it sitsFirst transcribed nucleotide, behind the capAdenosines across the transcript body
How many per transcriptOne defined positionOften several, each with its own level
What it is read againstCap handling, decapping, transcript stabilitySplicing, nuclear export, translation, stability
What a plain enrichment profile reportsBoth, mixed togetherBoth, mixed together
What separates themA route that keys on the cap rather than on the mark — an exonuclease step digests inward from the free end while the cap protects what is behind itAn antibody-free single-base route that resolves each adenosine

03How to read the cap end

  • Decide which position the claim is about. A statement about transcript stability and a statement about a site in the coding sequence are different studies, and the mark alone does not distinguish them.
  • Use a route that keys on the cap. The cap-proximal position is defined by the cap structure, so a method that relies on antibody binding to the mark cannot separate it from the body of the transcript.
  • Read internal m6A on the single-base line. Where both questions are live, they are answered by different methods on the same material rather than by one profile interpreted twice.
  • Expect a per-transcript answer at the cap. The position is a property of the capped end, so the readout is the m6Am status of transcripts, compared across conditions.
  • Pair it with a consequence. Stability, decapping or translation initiation are the readouts that turn the cap-proximal state into a biological statement.
  • Watch the cap m7G as well. The cap carries its own methylation, and internal m7G sites share that chemistry elsewhere in the transcript — the same positional problem, on a second mark.

04Limits and common misreadings

  • An m6A profile does not report m6Am. Standard enrichment captures the mark, not the position, so its signal mixes the cap end with the transcript body.
  • The two positions do not imply each other. A transcript with a methylated cap-proximal adenosine may carry no internal m6A at all, and the reverse holds too.
  • A cap-proximal result is not a single-base call on the transcript. It is a statement about a defined position in a population of molecules, not a ratio at every adenosine in the transcript.
  • Effects are not transferred between the positions. An effect reported for the cap-proximal position is not evidence for internal methylation, or the reverse; the literature discusses them separately for that reason.
  • The 5′ end is also structural. The cap carries the m7G that defines it, so a study of the cap end that ignores the cap itself has described only part of the structure it is talking about.

06FAQ

Why does the same enzyme keep appearing on both positions?

Because the chemistry is identical. An enzyme that acts on the methyl group has no reason to prefer one position over the other from the mark alone, which is exactly why the position has to be established by the method rather than assumed from the enzyme.

Can a study report both positions?

Yes, and where both are relevant it should, because the two positions do not imply each other. They come from two methods run on the same material: the cap-keyed route for the end of the transcript, and a single-base route for the body, which is what keeps an effect from being assigned to the wrong position.

Is the cap-proximal mark a fraction or a yes/no state?

A fraction. Across the molecules of one transcript, some carry the methyl group at that position and some do not, and the profile reports the state of the population. That is why the readout is compared across conditions rather than read as a single-base call at every adenosine in the transcript.

What is the first thing to check in a paper that reports an m6A effect?

Which position was measured, and by which route. If the answer is a profile that does not separate the cap from the transcript body, the effect cannot be assigned to either, because standard enrichment captures the mark rather than the position and mixes the two together.

Discuss your RNA modification project

Tell us the modification of interest and the sample type — we will come back with a suitable workflow.